Cortexin effectiveness in circulatory encephalopathy
Comparison in people · 1999
- What was studied
- 76 patients with dyscirculatory encephalopathy: 45 adjunctive Cortexin, 31 standard care
- Main finding
- Reports neurological and cognitive changes with nasal-electrophoresis delivery alongside standard care.
Rehabilitation efficiency · 22.7% improvement reported with add-on Cortexin · The abstract does not define the denominator or scoring formula for this percentage
Reported findings and study design
76 patients with stage I–II dyscirculatory encephalopathy: standard care 31 versus standard care plus nasal-electrophoresis Cortexin 45.
Population or model 76 patients with dyscirculatory encephalopathy: 45 adjunctive Cortexin, 31 standard care
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Rehabilitation efficiency | 22.7% improvement reported with add-on Cortexin | The abstract does not define the denominator or scoring formula for this percentage |
Values describe this study and its comparison. Unreported effect sizes and missing denominators have not been inferred.
Source for these results ↗ · Reviewed 2026-10-29
Study limitations and source details
Study limitations
- The abstract does not establish randomization or blinding.
- Delivery route and clinical population differ from other Cortexin reports.
Source details
Indexed abstract and citation checked via Europe PMC / PubMed; full methods and risk of bias not appraised.
Sources checked
Citation
Khavinson VKh, Morozov VG, Rybnikov VIu, Zakutskiĭ NG. Cortexin effectiveness in circulatory encephalopathy Klin Med (Mosk) 77(4):42-45. PMID 10356917